PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 201 filers reported holding PTC THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $7,076,580 | -17.9% | 174,000 | -2.2% | 0.88% | -49.6% |
Q1 2023 | $8,622,320 | +125.9% | 178,000 | +78.0% | 1.74% | +116.9% |
Q4 2022 | $3,817,000 | -53.4% | 100,000 | -38.7% | 0.80% | -49.6% |
Q3 2022 | $8,183,000 | +95.2% | 163,000 | +55.7% | 1.59% | +84.5% |
Q2 2022 | $4,193,000 | +167.6% | 104,656 | +149.2% | 0.86% | +111.3% |
Q1 2022 | $1,567,000 | -12.6% | 42,000 | -6.7% | 0.41% | -17.7% |
Q4 2021 | $1,792,000 | -50.4% | 45,000 | -53.7% | 0.50% | -52.3% |
Q3 2021 | $3,613,000 | -22.4% | 97,100 | -11.8% | 1.04% | -18.9% |
Q2 2021 | $4,654,000 | -1.8% | 110,100 | +10.0% | 1.28% | -5.4% |
Q1 2021 | $4,740,000 | +158.0% | 100,100 | +232.6% | 1.35% | +148.0% |
Q4 2020 | $1,837,000 | +30.6% | 30,100 | 0.0% | 0.55% | +27.0% |
Q3 2020 | $1,407,000 | -7.6% | 30,100 | +0.3% | 0.43% | -5.7% |
Q2 2020 | $1,522,000 | – | 30,000 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |